Table 4. Elevated UACR quartiles associated with the prevalence of MetS components.

		UACR quartiles OR (95%CI)
		Q1	Q2	Q3	Q4	P trend
Central obesity	Model 1	1.00	1.09(0.96–1.25)	1.28(1.12–1.46)	1.58(1.38–1.80)	<0.0001
	Model 2	1.00	1.07(0.94–1.22)	1.21(1.06–1.39)	1.43(1.25–1.63)	<0.0001
High BP	Model 1	1.00	1.07(0.94–1.21)	1.16(1.02–1.32)	1.71(1.50–1.95)	<0.0001
	Model 2	1.00	1.06(0.93–1.20)	1.15(1.01–1.30)	1.64(1.43–1.87)	<0.0001
Hyperglycemia	Model 1	1.00	1.04(0.88–1.23)	1.16(0.98–1.37)	1.61(1.37–1.88)	<0.0001
	Model 2	1.00	1.03(0.87–1.22)	1.13(0.96–1.33)	1.52(1.30–1.78)	<0.0001
Low HDL-C	Model 1	1.00	1.15(1.01–1.31)	1.23(1.08–1.40)	1.17(1.03–1.33)	0.0106
	Model 2	1.00	1.09(0.95–1.25)	1.19(0.99–1.36)	1.09(0.95–1.25)	0.1194
High Triglycerides	Model 1	1.00	1.24(1.09–1.41)	1.16(1.02–1.32)	1.28(1.12–1.45)	0.0017
	Model 2	1.00	1.18(1.03–1.35)	1.08(0.94–1.24)	1.19(1.04–1.37)	0.0479

Abbreviations: OR, odds ratio; CI: confidence interval; BP, blood pressure; HDL-C, high-density lipoprotein cholesterol; BMI, body mass index;

Model 1 adjusted for sex, age, BMI (except for central obesity), LDL-C, FINS, eGFR, serum albumin, smoking status, family history of diabetes;

Model 2 adjusted for all confounders in Model 1 plus central obesity (except for central obesity), high BP (except for high BP), hyperglycemia (except for hyperglycemia), low HDL (except for low HDL-C), high triglycerides (except for high triglycerides).